Cargando…

(18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer

PURPOSE: This study aimed to assess the value of (18)F-PSMA-1007 positron emission tomography/computed tomography (PET/CT)-derived semi-quantitative parameters of primary tumor for risk stratification of newly diagnosed prostate cancer (PCa). METHODS: Sixty patients referred for (18)F-PSMA-1007 PET/...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Siying, Li, Yanmei, Chen, Jian, Li, Yongliang, Yang, Pengfei, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768475/
https://www.ncbi.nlm.nih.gov/pubmed/36568229
http://dx.doi.org/10.3389/fonc.2022.1025930
_version_ 1784854176477478912
author Dong, Siying
Li, Yanmei
Chen, Jian
Li, Yongliang
Yang, Pengfei
Li, Juan
author_facet Dong, Siying
Li, Yanmei
Chen, Jian
Li, Yongliang
Yang, Pengfei
Li, Juan
author_sort Dong, Siying
collection PubMed
description PURPOSE: This study aimed to assess the value of (18)F-PSMA-1007 positron emission tomography/computed tomography (PET/CT)-derived semi-quantitative parameters of primary tumor for risk stratification of newly diagnosed prostate cancer (PCa). METHODS: Sixty patients referred for (18)F-PSMA-1007 PET/CT imaging for primary PCa were retrospectively analyzed and classified into the low-intermediate-risk (LIR) or high-risk (HR) group. The maximum standardized uptake value (SUVmax) of primary tumor, prostate total lesion PSMA (TL-PSMAp), and prostate PSMA-tumor volume (PSMA-TVp) were measured, and group differences were evaluated using the Mann–Whitney U test. Spearman’s correlation was performed to assess the correlation between the above parameters with prostate-specific antigen (PSA) levels and Gleason score (GS). Receiver operating characteristic (ROC) curve analysis was used to determine optimal cut-off values for SUVmax, TL-PSMAp, and PSMA-TVp to identify high-risk PCa and compare diagnostic efficacy. RESULTS: Among 60 patients, 46 were assigned to the HR group and 16 to the LIR group. In all patients, SUVmax, TL-PSMAp, and PSMA-TVp were moderately correlated with pre-treatment PSA values (r = 0.411, p = 0.001; r = 0.663, p < 0.001; and r = 0.549, p < 0.001, respectively). SUVmax and TL-PSMAp were moderately correlated with GS (r = 0.457 and r = 0.448, respectively; p < 0.001), while PSMA-TVp was weakly correlated with GS (r = 0.285, p = 0.027). In the ROC curve analysis, the optimal cut-off values of SUVmax, TL-PSMAp, and PSMA-TVp for identifying high-risk PCa were 9.61, 59.62, and 10.27, respectively, and the areas under the operating curve were 0.828, 0.901, and 0.809, respectively. The sensitivities of SUVmax, TL-PSMAp, and PSMA-TVp were 91.03%, 71.74%, and 63.04%, respectively, and the specificities were 71.43%, 100.00%, and 92.86%, respectively. CONCLUSIONS: TL-PSMAp had a superior ability to identify high-risk PCa. The semi-quantitative parameters of primary tumor on (18)F-PSMA-1007 PET/CT imaging can be an objective imaging reference index to determine PCa risk stratification.
format Online
Article
Text
id pubmed-9768475
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97684752022-12-22 (18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer Dong, Siying Li, Yanmei Chen, Jian Li, Yongliang Yang, Pengfei Li, Juan Front Oncol Oncology PURPOSE: This study aimed to assess the value of (18)F-PSMA-1007 positron emission tomography/computed tomography (PET/CT)-derived semi-quantitative parameters of primary tumor for risk stratification of newly diagnosed prostate cancer (PCa). METHODS: Sixty patients referred for (18)F-PSMA-1007 PET/CT imaging for primary PCa were retrospectively analyzed and classified into the low-intermediate-risk (LIR) or high-risk (HR) group. The maximum standardized uptake value (SUVmax) of primary tumor, prostate total lesion PSMA (TL-PSMAp), and prostate PSMA-tumor volume (PSMA-TVp) were measured, and group differences were evaluated using the Mann–Whitney U test. Spearman’s correlation was performed to assess the correlation between the above parameters with prostate-specific antigen (PSA) levels and Gleason score (GS). Receiver operating characteristic (ROC) curve analysis was used to determine optimal cut-off values for SUVmax, TL-PSMAp, and PSMA-TVp to identify high-risk PCa and compare diagnostic efficacy. RESULTS: Among 60 patients, 46 were assigned to the HR group and 16 to the LIR group. In all patients, SUVmax, TL-PSMAp, and PSMA-TVp were moderately correlated with pre-treatment PSA values (r = 0.411, p = 0.001; r = 0.663, p < 0.001; and r = 0.549, p < 0.001, respectively). SUVmax and TL-PSMAp were moderately correlated with GS (r = 0.457 and r = 0.448, respectively; p < 0.001), while PSMA-TVp was weakly correlated with GS (r = 0.285, p = 0.027). In the ROC curve analysis, the optimal cut-off values of SUVmax, TL-PSMAp, and PSMA-TVp for identifying high-risk PCa were 9.61, 59.62, and 10.27, respectively, and the areas under the operating curve were 0.828, 0.901, and 0.809, respectively. The sensitivities of SUVmax, TL-PSMAp, and PSMA-TVp were 91.03%, 71.74%, and 63.04%, respectively, and the specificities were 71.43%, 100.00%, and 92.86%, respectively. CONCLUSIONS: TL-PSMAp had a superior ability to identify high-risk PCa. The semi-quantitative parameters of primary tumor on (18)F-PSMA-1007 PET/CT imaging can be an objective imaging reference index to determine PCa risk stratification. Frontiers Media S.A. 2022-12-07 /pmc/articles/PMC9768475/ /pubmed/36568229 http://dx.doi.org/10.3389/fonc.2022.1025930 Text en Copyright © 2022 Dong, Li, Chen, Li, Yang and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Dong, Siying
Li, Yanmei
Chen, Jian
Li, Yongliang
Yang, Pengfei
Li, Juan
(18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
title (18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
title_full (18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
title_fullStr (18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
title_full_unstemmed (18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
title_short (18)F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
title_sort (18)f-psma-1007 pet/ct-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768475/
https://www.ncbi.nlm.nih.gov/pubmed/36568229
http://dx.doi.org/10.3389/fonc.2022.1025930
work_keys_str_mv AT dongsiying 18fpsma1007petctderivedsemiquantitativeparametersforriskstratificationofnewlydiagnosedprostatecancer
AT liyanmei 18fpsma1007petctderivedsemiquantitativeparametersforriskstratificationofnewlydiagnosedprostatecancer
AT chenjian 18fpsma1007petctderivedsemiquantitativeparametersforriskstratificationofnewlydiagnosedprostatecancer
AT liyongliang 18fpsma1007petctderivedsemiquantitativeparametersforriskstratificationofnewlydiagnosedprostatecancer
AT yangpengfei 18fpsma1007petctderivedsemiquantitativeparametersforriskstratificationofnewlydiagnosedprostatecancer
AT lijuan 18fpsma1007petctderivedsemiquantitativeparametersforriskstratificationofnewlydiagnosedprostatecancer